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Introduction: Dengue fever is one of the commonest mosquito-borne diseases in the tropics, and Sri Lanka is no
exception. Despite its commonness, dengue fever has rarely been described among patients who have undergone
transplantation. We report the case of a patient with dengue fever after liver transplantation, which, to the best of
our knowledge, is the first such reported case outside Brazil.
Case presentation: Our patient was a 46-year-old Sri Lakan man who presented to our institution two years after
undergoing an ABO-compatible cadaveric liver transplant. At presentation, he had typical symptoms of dengue fever.
He was taking prednisolone 5mg daily and tacrolimus 3mg twice daily as immunosuppression. Initial investigations
showed thrombocytopenia and neutropenia that reached a nadir by day 7 of his illness. He had elevated liver enzymes
as well. The diagnosis was confirmed on the basis of NS1 antigen detection by enzyme-linked immunosorbent assay.
His blood cultures and polymerase chain reaction tests for cytomegalovirus were negative. He made an uneventful
recovery and was discharged by day 9 of his illness. However, normalization of liver function took nearly two
weeks. In three previously reported Brazilian cases of dengue after liver transplantation, the patients presented
with dengue shock syndrome, in contrast to the relatively milder presentation of our patient. Because of the lack
of case reports in the literature, it is difficult to ascertain the risk factors for severe dengue infection in transplants,
but dengue fever reported in renal transplants sheds some light on them. High-dose steroids increase the risk of
thrombocytopenia, whereas tacrolimus has been reported to prolong the duration of symptoms. Otherwise, dengue
fever is a relatively mild illness in patients who have undergone renal transplantation, and renal allograft survival has
been reported to be 86% following dengue fever.
Conclusion: Dengue is a rarely reported infection in patients who have undergone transplantation. A high degree of
suspicion is required for diagnosis. Dengue NS1 antigen detection is a useful addition to the already existing methods
of diagnosis. Steroids and tacrolimus have effects on the morbidity of the disease. Graft outcomes following the infection
has been excellent in all reported cases.
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Dengue fever (DF) is one of the commonest mosquito-
borne diseases in the tropics and has become hyperen-
demic in Sri Lanka. Although thousands of cases are
reported yearly in Sri Lanka, dengue has been a rarely
reported disease in patients who have undergone trans-
plantation [1]. We describe the case of a patient with DF* Correspondence: rangamw2003@yahoo.com
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article, unless otherwise stated.after a liver transplant (LT). To the best of our knowledge,
this is the first such reported case outside Brazil.
Case presentation
A 46-year-old Sri Lankan man presented to our institution
with high-grade fever associated with severe retro-ocular
pain, photophobia, bone pain and severe body aches of
three days’ duration. He was a recipient of an ABO-
compatible cadaveric LT 26 months previously for treat-
ment of end-stage cryptogenic cirrhosis. The immediate
post-transplant period had been complicated by acute
rejection, but he made a full recovery with an allograft. Hentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Weerakkody et al. Journal of Medical Case Reports 2014, 8:378 Page 2 of 4
http://www.jmedicalcasereports.com/content/8/1/378was maintained on prednisolone 5mg daily and tacrolimus
3mg twice daily. He had developed diabetes after the third
month post-LT. His two sons had had a febrile illness,
diagnosed as DF, one week before coming to our insti-
tution. He did not complain of respiratory, urinary or
bowel symptoms or a rash. An examination did not reveal
jaundice, rashes or neck stiffness, but demonstrated a fine
tremor in outstretched hands. His right frontal sinus was
tender on palpation.
His initial full blood count revealed thrombocytopenia
(90,000/μL), and, with a suggestive clinical picture, a
provisional diagnosis of DF was made. His skull X-ray
demonstrated a fluid level in the right frontal sinus con-
firming acute sinusitis, which was treated with intravenous
ceftriaxone 1g twice daily. Over the next few days, his
white cell count and platelet count gradually dropped,
reaching a nadir by day 4 of the illness. Dengue NS1 anti-
gen was detected in his day 3 serum sample, confirming
the diagnosis of DF. His liver enzymes rose sharply until
day 7 before starting to recover. His bilirubin levels and
coagulation profile were normal. He entered the leakage
(critical) phase on day 6 of his illness, and he recovered by
day 8 without any complications with standard supportive
DF management. DNA detection of cytomegalovirus was
negative, and his blood cultures were sterile. However,
liver enzyme normalization took more than two weeks.
Throughout his hospital stay, his serum creatinine was
around 140μmol/L and, together with fine tremors, was
suggestive of tacrolimus toxicity (T0 = 13.4ng/dL). Tacroli-
mus was reduced to 4mg daily as a result. His creatinine
levels dropped to 104μmol/L by the time of discharge.
The day 7 and day 14 dengue immunoglobulin M (IgM)
titers showed an eightfold increase. Figure 1 shows the
changes in parameters over time.
Discussion
DF is the most widespread mosquito-borne disease in Sri
Lanka. Despite the high prevalence, it is a rarely reportedFigure 1 Graphical representation of changing hematological and bio
WBC, White blood cell.disease in patients who have received solid-organ trans-
plants. Patients who have undergone transplantation may
have diminished T-cell responses and may be at low risk
for contracting DF, which perhaps accounts for the lack of
clinical reports describing such patients [2]. In addition,
there are relatively few patients living with allografts in
Sri Lanka. Our literature search showed only three cases,
all of which were in Brazil [3,4] and were diagnosed as
dengue shock syndrome (DSS). One of these patients had
jaundice, a lowest platelet count of 30,000/μL and ex-
tremely high liver enzyme levels in the range of 104U/L.
The laboratory examination findings for the other two
previously reported patients are not available. Our patient
had lower platelet counts than these patients, but his liver
enzymes were much lower and he never had jaundice.
One of the previously reported patients developed DSS
three weeks following the transplant [4], and the other
two contracted it in the ninth month post-transplantation
[3]. Contrary to the pattern in the previously reported
cases, our patient developed the illness two years after
transplantation. The clinical picture was that of DF, not
DSS as in the previously reported cases. Our patient had a
fever pattern that is different from that seen in normal DF,
by virtue of a prolonged febrile phase, which ran up to
one week. Superadded sinusitis may have had an effect on
the length of the febrile phase. Photophobia is an uncom-
mon symptom of DF, but dengue meningoencephalitis can
present with that symptom. Sinus tenderness and an
abnormal X-ray view of the sinuses makes diagnosis of
acute frontal sinusitis more likely. A lumbar puncture
and CSF analysis would have been extremely useful in
this situation, but the rapid resolution of symptoms
with antibiotics and in the face of thrombocytopenia,
lumbar puncture was not tried.
Although data on LT are limited, data from a large case
series on patients who received renal transplants (RTs)
have been reported [5]. Nasim and colleagues reported
that the mean duration of high-grade fever was 3.4 ± 1.5chemical parameters. Hb, Hemoglobin; PCV, Packed cell volume;
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patient went through a febrile phase that was similar in
length, but his fever was high-grade. In the patients
described by Nasim and colleagues, severe primary
disease was seen more often in patients receiving high
doses of steroids (>7.5mg/d) compared to low-dose reg-
imens (≤7.5mg/d). Thrombocytopenia was most severe
in patients receiving steroids, azathioprine (AZA) and
cyclosporin A (CyA) concomitantly. Mycophenolate
mofetil (MMF) or AZA had no effect on the severity
of thrombocytopenia, whereas tacrolimus prolonged
the duration of thrombocytopenia compared to MMF or
AZA alone or to either one in combination with CyA [5].
The deaths that occurred were not related to DF, and graft
survival was excellent (86%) following the infection.
Diagnosing DF is challenging in patients who have
undergone transplantation, owing to immunosuppression,
which may suppress some of the cardinal features of DF.
The diagnosis may be delayed if fever and thrombocytopenia
are initially attributed to co-morbidities such as cytomegalo-
virus sepsis or because of anti-mitotic agents or hepatitis C
virus [5]. It is prudent to believe that most of the infections
in patients with immunosuppression may be subclinical and
indistinguishable from a non-specific viral fever and, as
a result, may never be reported. The actual infection rates
could be much higher than reported. Additionally, the
diagnosis in the previously reported cases, as well as in
series where RT was involved, were arrived at using anti-
body (IgM) detection. In comparison, we used both NS1
antigen detection and IgM titer. Dengue NS1 antigen
detection has better sensitivity and specificity than other
methods of detection of dengue virus [6] and provide con-
firmation of the diagnosis as early as day 3 of illness. We
believe that use of antigen detection as a screening test
will help to diagnose more cases of DF in patients who
have received transplants. In almost all patients with DF,
the infection is vector-borne. Interestingly, hematogenic
spread of dengue has also been reported in patients who
have undergone transplantation [7], from the donor via
the allograft, which is the only record of mortality.
Data on sequelae following DF in LT patients are scarce
because of the extremely limited number of cases reported
in the literature to date. Data from case series involving
RT patients show no increase in graft failures or episodes
of acute rejection [8]. Although it included no patients
with DF who had received LTs, a Taiwan series showed
an increased incidence of biliary atresia following a DF
epidemic in 2002 [9].
Conclusions
DF is a rarely reported infection in transplanted
patients and requires a high degree of suspicion for proper
diagnosis. Dengue NS1 antigen detection is a useful
addition to the already existing methods of diagnosis.Steroids and tacrolimus increase the morbidity of the
disease. The graft outcome following the infection in
our patient has been excellent, as in previously reported
cases.Consent
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